Tushar Patel reports 17.6% stake in Amneal

Tushar Patel filed Amendment No. 6 reporting his beneficial ownership of Amneal Pharmaceuticals Class A common stock.

Rhea-AI Filing Summary

Tushar Patel filed Amendment No. 6 reporting his beneficial ownership of Amneal Pharmaceuticals Class A common stock. He beneficially owns 61,341,678 shares, representing 17.6% of the Class A common stock outstanding, with sole voting and dispositive power over all of these shares.

The ownership percentage is based on 348,296,017 shares of Class A common stock outstanding as of August 10, 2026 plus 28,942,098 shares issued in connection with Amneal’s acquisition of Kashiv BioSciences. As part of this transaction, Amneal Pharmaceuticals LLC agreed to pay the Kashiv sellers an aggregate of $375,000,000 in cash, subject to adjustments, and Amneal was required to issue an aggregate of 28,942,098 Amneal Class A shares to the sellers, including Rock Nola, LLC. Rock Nola, whose sole member is a trust controlled by Patel, received 12,763,469 shares, contributing to Patel’s reported beneficial ownership, which also includes shares held by TI SIE 2.

Filing Explained

The amendment confirms that the Kashiv Acquisition closed on August 10, 2026: Amneal LLC acquired all of Kashiv’s membership interests, while the transaction’s stated closing mechanics required $375,000,000 in cash, subject to adjustments, and 28,942,098 Class A shares for the sellers.

Key Figures

Beneficial ownership: 61,341,678 shares Ownership percentage: 17.6% Kashiv cash consideration: $375,000,000 +4 more

7 metrics

Beneficial ownership 61,341,678 shares Shares of Amneal Class A common stock beneficially owned by Tushar Patel

Ownership percentage 17.6% Percent of Amneal Class A common stock represented by Tushar Patel’s beneficial ownership

Kashiv cash consideration $375,000,000 Aggregate cash Amneal Pharmaceuticals LLC was required to pay Kashiv sellers, subject to adjustments

Shares issued in Kashiv acquisition 28,942,098 shares Aggregate Amneal Class A shares issued to Kashiv sellers in the Kashiv Acquisition

Shares received by Rock Nola 12,763,469 shares Amneal Class A shares issued to Rock Nola, LLC in the Kashiv Acquisition

Shares outstanding baseline 348,296,017 shares Amneal Class A shares outstanding as of August 10, 2026, before Kashiv issuance baseline

TI SIE 2 holdings 48,578,209 shares Amneal Class A shares held of record by TI SIE 2 included in Patel’s beneficial ownership

Key Terms

Schedule 13D, beneficially owned, Membership Interest Purchase Agreement, sole voting power, +2 more

6 terms

Schedule 13D regulatory

"filed with the SEC on July 9, 2018 (the "Initial 13D""

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

beneficially owned financial

"aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Membership Interest Purchase Agreement regulatory

"entered into a Membership Interest Purchase Agreement (the "Purchase Agreement"), by and among the Issuer, Kashiv"

A membership interest purchase agreement is a contract used when someone buys an ownership stake in a limited liability company (LLC). It spells out what is being sold, the price, any promises about the business’s condition, and who takes responsibility for debts or legal issues—like a receipt and rulebook for the sale. Investors care because it transfers control, affects future cash flow and liabilities, and can change the value and tax treatment of their investment.

sole voting power financial

"Sole power to vote or to direct the vote - 61,341,678"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole power to dispose or to direct the disposition - 61,341,678"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

purchase price adjustments financial

"pay to the Sellers, including Rock Nola, an aggregate amount of $375,000,000 in cash, subject to certain purchase price adjustments"

Purchase price adjustments are changes made to the agreed sale price of a company after closing to reflect actual financial facts—like cash on hand, debts, or inventory—found when final accounts are prepared. Think of it as the final bill after a home inspection: the buyer and seller settle differences so the price matches reality. For investors, these adjustments affect the true cost, future earnings and cash flow from a deal, and therefore the value of the investment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AMRX shares does Tushar Patel report owning in this Schedule 13D/A?

Tushar Patel reports beneficial ownership of 61,341,678 shares of Amneal Pharmaceuticals Class A common stock, with sole voting and dispositive power over all of these shares as of August 10, 2026.

What percentage of Amneal (AMRX) does Tushar Patel beneficially own?

Tushar Patel beneficially owns 17.6% of Amneal’s Class A common stock. This is based on 348,296,017 shares outstanding plus 28,942,098 shares issued in the Kashiv acquisition.

How was the Kashiv BioSciences acquisition by Amneal (AMRX) structured?

In the Kashiv acquisition, Amneal Pharmaceuticals LLC agreed to pay sellers $375,000,000 in cash, subject to adjustments, and Amneal was required to issue an aggregate of 28,942,098 shares of Class A common stock to the Kashiv sellers.

How many AMRX shares did Rock Nola receive in the Kashiv transaction?

Rock Nola, LLC, whose sole member is a trust controlled by Tushar Patel, was issued 12,763,469 shares of Amneal Class A common stock in connection with the Kashiv acquisition completed on August 10, 2026.

Which entities’ AMRX holdings are included in Tushar Patel’s beneficial ownership?

Tushar Patel’s beneficial ownership includes 48,578,209 shares held of record by TI SIE 2 and 12,763,469 shares held of record by Rock Nola, LLC, totaling his 61,341,678 reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 06:05 PM Accepted by SEC EDGAR 08/12/2026 - 06:05 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 6)

Amneal Pharmaceuticals, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.01

(Title of Class of Securities)

03168L105

(CUSIP Number)

Edward Coss
520 Newport Center Drive, Twenty-First Floor
Newport Beach, CA, 92660
(949) 610-8022

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/10/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 03168L105

1

Name of reporting person

Tushar Patel

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 61,341,678.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 61,341,678.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

61,341,678.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

17.6 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 348,296,017 shares of Class A Common Stock outstanding as of August 10, 2026, which reflects the amount reported in the Issuer's Quarterly Report on Form 10-Q filed on August 6, 2026, plus 28,942,098 shares of Class A Common Stock issued in connection with the Kashiv Acquisition (as defined below), as reported in the Issuer's Current Report on Form 8-K filed on August 10, 2026.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Class A Common Stock, par value $0.01
(b)	Name of Issuer: Amneal Pharmaceuticals, Inc.
(c)	Address of Issuer's Principal Executive Offices: 400 CROSSING BOULEVARD, 3RD FLOOR, BRIDGEWATER, NEW JERSEY , 08807.
Item 3.	Source and Amount of Funds or Other Consideration
	The disclosure in Item 3 is hereby amended and supplemented by adding the following: On April 21, 2026, Rock Nola, LLC, a Delaware limited liability company ("Rock Nola") the sole member of which is a trust controlled by the Reporting Person, entered into a Membership Interest Purchase Agreement (the "Purchase Agreement"), by and among the Issuer, Kashiv BioSciences, LLC ("Kashiv"), KB Seller Representative, LLC (the "Seller Representative") and the equityholders of Kashiv named therein, including Rock Nola (the "Sellers"). On August 10, 2026, pursuant to the Purchase Agreement, Amneal Pharmaceuticals LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Amneal LLC"), acting pursuant to the terms and conditions of a previously executed assignment and assumption agreement between it, Amneal, Kashiv and the Seller Representative, purchased from the Sellers, including Rock Nola, and the Sellers, including Rock Nola sold, conveyed, assigned, transferred and delivered to Amneal LLC, 100% of the issued and outstanding membership interests of Kashiv (the "Kashiv Acquisition"). Pursuant to the Purchase Agreement, at the closing of the Kashiv Acquisition, (i) Amneal LLC was required to pay to the Sellers, including Rock Nola, an aggregate amount of $375,000,000 in cash, subject to certain purchase price adjustments, and (ii) Amneal was required to issue to the Sellers, including Rock Nola, an aggregate of 28,942,098 shares of Class A Common Stock. Rock Nola was issued 12,763,469 shares of Class A Common Stock in connection with the Kashiv Acquisition.
Item 4.	Purpose of Transaction
	This Amendment No. 6 to Schedule 13D (this "Amendment No. 6") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 6, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the Issuer. Capitalized terms used but not defined in this Amendment No. 6 shall have the meanings set forth in the Schedule 13D.
Item 5.	Interest in Securities of the Issuer
(a)	The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 348,296,017 shares of Class A Common Stock outstanding as of August 10, 2026, which reflects the amount reported in the Issuer's Quarterly Report on Form 10-Q filed on August 6, 2026, plus 28,942,098 shares of Class A Common Stock issued in connection with the Kashiv Acquisition, as reported in the Issuer's Current Report on Form 8-K filed on August 10, 2026:
(b)	Reporting Person - Tushar Patel Amount beneficially owned - 61,341,678 Percent of class - 17.6 Sole power to vote or to direct the vote - 61,341,678 Shared power to vote or to direct the vote - 0 Sole power to dispose or to direct the disposition - 61,341,678 Shared power to dispose or to direct the disposition - 0 The Reporting Person may be deemed to beneficially own 48,578,209 shares of Class A Common Stock held of record by TI SIE 2 and 12,763,469 shares of Class A Common Stock held of record by Rock Nola.
(c)	The information set forth in Item 3 of this Amendment No. 6 is incorporated by reference herein
(d)	None.
(e)	Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Tushar Patel

Signature:	/s/ Tushar Patel
Name/Title:	Tushar Patel
Date:	08/12/2026